ConductScience.org, home

Trial · NCT03629249

Results by group87

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Overall PopulationQAW039 150 mg219.67Full Range 0 to 9241.27milligrams (mg)
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Overall PopulationQAW039 450 mg193.02Full Range 0 to 5184.19milligrams (mg)
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Overall PopulationPlacebo223.22Full Range 0 to 9552.69milligrams (mg)
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Subpopulation of Patients With High Eosinophil Count (≥ 250 Cells/µl)QAW039 150 mg210.88Full Range 0 to 5352.80milligrams (mg)
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Subpopulation of Patients With High Eosinophil Count (≥ 250 Cells/µl)QAW039 450 mg185.29Full Range 0 to 5184.19milligrams (mg)
Total Systemic Corticosteroid Dose in mg Prednisone/Prednisolone or Equivalent Over 52 Weeks in the Subpopulation of Patients With High Eosinophil Count (≥ 250 Cells/µl)Placebo212.66Full Range 0 to 9552.69milligrams (mg)
Change From Baseline in Daytime Symptom ScoresQAW039 150 mgWeek 1-4-0.12Standard Deviation 0.494score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 450 mgWeek 1-4-0.12Standard Deviation 0.497score on scale
Change From Baseline in Daytime Symptom ScoresPlaceboWeek 1-4-0.09Standard Deviation 0.459score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 150 mgWeek 5-8-0.21Standard Deviation 0.615score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 450 mgWeek 5-8-0.25Standard Deviation 0.570score on scale
Change From Baseline in Daytime Symptom ScoresPlaceboWeek 5-8-0.17Standard Deviation 0.561score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 150 mgWeek 9-12-0.29Standard Deviation 0.632score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 450 mgWeek 9-12-0.36Standard Deviation 0.588score on scale
Change From Baseline in Daytime Symptom ScoresPlaceboWeek 9-12-0.17Standard Deviation 0.605score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 150 mgWeek 13-16-0.32Standard Deviation 0.644score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 450 mgWeek 13-16-0.37Standard Deviation 0.653score on scale
Change From Baseline in Daytime Symptom ScoresPlaceboWeek 13-16-0.17Standard Deviation 0.629score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 150 mgWeek 17-20-0.30Standard Deviation 0.570score on scale
Change From Baseline in Daytime Symptom ScoresQAW039 450 mgWeek 17-20-0.35Standard Deviation 0.759score on scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03629249/results